Reputation · trust score
A transparent 0–100 signal. Every entity starts at a neutral baseline of 65; threat-intel blocklists, exposure, reverse-DNS, routing and allocation each adjust it up or down. Higher is more trustworthy.
- Baseline (neutral) 65
- Trust score 65 / 100
Experimental · trust-vectors model v1.2.0 — a transparent heuristic, not a definitive verdict. How it works →
Top CIDR ranges
| CIDR | IPs | PTR Density | Organization | Country | State | City |
|---|---|---|---|---|---|---|
| 160.61.168.0/22 | 1.0K |
0.0%
|
Novartis AG | CH | — | — |
| 160.62.4.0/22 | 1.0K |
1.8%
|
Novartis AG | CH | Aargau | Magden |
| 160.62.2.0/23 | 512 |
0.0%
|
Novartis AG | CH | — | — |
| 160.61.208.0/24 | 256 |
0.0%
|
Novartis AG | CH | — | — |
| 160.61.211.0/24 | 256 |
0.0%
|
Novartis AG | CH | — | — |
| 160.62.1.0/24 | 256 |
4.3%
|
Novartis AG | CH | — | — |
BGP Announced Prefixes
Live BGP anomalies →Prefixes AS25031 actually originates in BGP, observed across our RIPE RIS collectors. This live routing view can differ from the registry allocation above.
| Prefix | Announcement samples | Last seen |
|---|---|---|
| 160.62.1.0/24 | 9,005 | 2026-07-29 06:06:00 |
| 160.62.5.0/24 | 8,370 | 2026-07-29 06:07:56 |
| 160.61.168.0/23 | 8,093 | 2026-07-29 06:07:56 |
| 160.62.4.0/24 | 8,080 | 2026-07-29 06:07:56 |
| 160.62.3.0/24 | 8,076 | 2026-07-29 06:07:56 |
| 160.62.2.0/24 | 8,060 | 2026-07-29 06:07:56 |
| 160.61.170.0/23 | 8,058 | 2026-07-29 06:07:56 |
| 160.62.6.0/24 | 8,035 | 2026-07-29 06:07:56 |
| 160.62.7.0/24 | 7,928 | 2026-07-29 06:08:28 |
| 160.61.208.0/24 | 4,311 | 2026-07-29 06:07:56 |
| 160.61.211.0/24 | 4,165 | 2026-07-29 06:08:19 |
Frequently Asked Questions
What is AS25031?
AS25031 is an Autonomous System Number assigned to Novartis AG. An ASN identifies a network that controls a specific set of IP addresses and determines how traffic is routed across the internet via BGP (Border Gateway Protocol).
How many IP addresses does AS25031 announce?
AS25031 announces 3.3K IPv4 addresses distributed across 6 routed CIDR prefixes. The network is registered in Switzerland.
Who operates AS25031?
AS25031 is operated by Novartis AG. The organization is based in Switzerland. You can view all IP ranges and related ASNs on the organization page.
What country is AS25031 registered in?
AS25031 is registered in Switzerland. This indicates where the network operator is headquartered, though the IP addresses it announces may serve users globally.
